» Authors » Raul Vivar

Raul Vivar

Explore the profile of Raul Vivar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 419
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Suarez-Rozas C, Jara J, Cortes G, Rojas D, Araya-Valdes G, Molina-Berrios A, et al.
Cancers (Basel) . 2024 Sep; 16(17). PMID: 39272835
Colorectal cancer (CRC) is the third leading cause of cancer deaths in the world. Standard drugs currently used for the treatment of advanced CRC-such as 5-fluorouracil (5FU)-remain unsatisfactory in their...
2.
Valderrama V, Sanchez P, Delso M, Diaz-Dosque M, Escobar A, Budini M, et al.
J Appl Microbiol . 2023 Dec; 135(1). PMID: 38148145
Aims: To evaluate the antifungal and antibiofilm activity of gallic acid derivatives TPP+-C10 and TPP+-C12 and their effects on mitochondrial function on two Candida albicans reference strains (ATCC 90029 and...
3.
Anfossi R, Vivar R, Ayala P, Gonzalez-Herrera F, Espinoza-Perez C, Osorio J, et al.
Front Cell Dev Biol . 2023 Oct; 11:1122408. PMID: 37799272
Cardiac fibroblasts (CF) are crucial cells in damaged heart tissues, expressing TLR4, IFN-receptor and responding to lipopolysaccharide (LPS) and interferon-β (IFN-β) respectively. While CF interact with immune cells; however, their...
4.
Gonzalez-Herrera F, Catalan M, Anfossi R, Maya J, Pedrozo Z, Diaz-Araya G, et al.
Cell Signal . 2023 Jun; 109:110778. PMID: 37343898
Cardiac fibroblasts (CFs) activation is a common response to most pathological conditions affecting the heart, characterized by increased cellular secretory capacity and increased expression of fibrotic markers, such as collagen...
5.
Gonzalez-Herrera F, Anfossi R, Catalan M, Gutierrez-Figueroa R, Maya J, Diaz-Araya G, et al.
Cell Signal . 2023 Mar; 106:110657. PMID: 36933776
Cardiac cells respond to various pathophysiological stimuli, synthesizing inflammatory molecules that allow tissue repair and proper functioning of the heart; however, perpetuation of the inflammatory response can lead to cardiac...
6.
Gonzalez-Herrera F, Clayton N, Guzman-Rivera D, Carrillo I, Castillo C, Catalan M, et al.
Front Immunol . 2023 Jan; 13:1035589. PMID: 36713380
Introduction: Chronic Chagasic cardiomyopathy (CCC), caused by the protozoan Trypanosoma cruzi, is the most severe manifestation of Chagas disease.CCC is characterized by cardiac inflammation and fibrosis caused by a persistent...
7.
Espitia-Corredor J, Boza P, Espinoza-Perez C, Lillo J, Rimassa-Tare C, Machuca V, et al.
Inflammation . 2022 Jul; 45(6):2498-2512. PMID: 35867264
Angiotensin II (Ang-II) is a widely studied hypertensive, profibrotic, and pro-inflammatory peptide. In the heart, cardiac fibroblasts (CF) express type 1 angiotensin II receptors (AT1R), Toll-like receptor-4 (TLR4), and the...
8.
Flores-Vergara R, Olmedo I, Aranguiz P, Riquelme J, Vivar R, Pedrozo Z
Front Physiol . 2021 Sep; 12:716721. PMID: 34539441
Communication between cells is a foundational concept for understanding the physiology and pathology of biological systems. Paracrine/autocrine signaling, direct cell-to-cell interplay, and extracellular matrix interactions are three types of cell...
9.
Olivares-Silva F, De Gregorio N, Espitia-Corredor J, Espinoza C, Vivar R, Silva D, et al.
Biochim Biophys Acta Mol Basis Dis . 2021 Aug; 1867(12):166241. PMID: 34400298
Aims: Despite the broad pharmacological arsenal to treat hypertension, chronic patients may develop irreversible cardiac remodeling and fibrosis. Angiotensin II, the main peptide responsible for the Renin-Angiotensin-Aldosterone-System, has been closely...
10.